Buscar resultados de ensayos clínicos
Neuromyelitis Optica - 57 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Neuromyelitis Optica (NMO) & Cetirizine Condición: Neuromyelitis Optica Fecha: 2016-08-09 Intervenciones: Drug: cetirizine Other Name: Zyrtec |
Completed |
Nombre del estudio: Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses Condición: Neuromyelitis Optica Fecha: 2014-03-11 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica Condición: Neuromyelitis Optica Fecha: 2011-04-18 Intervenciones: Procedure: AHSCT AHSCT Procedure: |
Completed |
Nombre del estudio: C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation Condición: Neuromyelitis Optica Fecha: 2012-12-29 Intervenciones: Drug: C1-esterase inhibitor (Cinryze) Other Name: Cinryze |
Completed |
Nombre del estudio: Safety and Tolerability of Rituximab in Neuromyelitis Optica Condición: Neuromyelitis Optica Fecha: 2007-07-12 Intervenciones: Drug: Rituximab Rituximab is a highly purified, 1328-amino acid antibody with an approximate molecular m |
Completed |
Nombre del estudio: Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy. Condición: Neuromyelitis Optica Spectrum Disorder Fecha: 2013-04-26 Intervenciones: Drug: NPB-01 Other Name: Intravenous immunoglobulin |
Completed |
Nombre del estudio: Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders Condición:
|
Completed |
Nombre del estudio: An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica Condición:
|
Active, not recruiting |
Nombre del estudio: Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses Condición:
|
Active, not recruiting |
Nombre del estudio: Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder Condición: Neuromyelitis Optica Spectrum Disorder Fecha: 2016-08-27 Intervenciones: Drug: Bortezomib Bortezomib will be subcutaneously applicated in 4 treatment cycles with 4 injections of |